IPO Search Results for Alopexx

Company	Ticker	Business Description	Underwriters	Offer Date
Alopexx	ALPX	Phase 2 biotech developing immune therapies for bacterial, fungal, and parasitic infections.	ThinkEquity	TBA

Showing 1 to 1 of 1 entries

News Results for Alopexx
Nano-cap biotech Alopexx cuts shares offered by 20% ahead of $12 million 09/09/24
US IPO Week Ahead: More micro-caps after a big week for IPOs 02/10/23
US IPO Week Ahead: Gene editing biotech plots the first $100+ million IPO of the 4Q 10/14/22
US IPO Week Ahead: Quiet October continues with trickle of small deals 10/07/22
US IPO Week Ahead: The IPO calendar returns to small deals 09/16/22
Infectious disease biotech Alopexx revises terms ahead of $15 million IPO 09/07/22
Infectious disease biotech Alopexx sets terms for $15 million IPO 08/24/22

Showing 1 to 7 of 7 entries